Focus
View

AbbVie Inc.

ABBV · FY2025

MISALIGNED

CEO Package

$32.5M

Pay Ratio

—

Robert A. Michael

Pay outran TSR by +62.0 pts

ABBOTT LABORATORIES

ABT · FY2025

ALIGNED

CEO Package

$24.2M

Pay Ratio

—

Robert B. Ford

Returns outran pay growth by +1.8 pts

Royalty Pharma plc

RPRX · FY2025

MIXED

CEO Package

$938K

Pay Ratio

—

Pablo Legorreta

Awaiting a fuller pay-performance history

CEOTotal Compensation — All Companies

ABBV$32.5MABT$24.2MRPRX$938K

All values are grant-date fair value as reported in proxy statements.

Key Differences

The fastest way to read this comparison before dropping into the tables.

ABBV carries the largest package at $32.5M, about 34.7x RPRX.
ABBV reads misaligned, while ABT looks aligned.
ABBV is the most equity-heavy package, while RPRX leans hardest on base salary.

Pay Component Breakdown

Latest CEO package mix by company. This stays on the CEO package even if the chart above is showing Top 5 pay.

ABBV

Robert A. Michael

$32.5M

base salary5%
stock awards41%
option awards10%
other compensation2%

ABT

Robert B. Ford

$24.2M

base salary6%
stock awards36%
option awards36%
non-equity incentive compensation8%
other compensation4%

RPRX

Pablo Legorreta

$938K

base salary100%

Quick Comparison

CompanyCEOLatest YearTotal Comp
AbbVie Inc.(ABBV)Robert A. Michael2025$32.5M
ABBOTT LABORATORIES(ABT)Robert B. Ford2025$24.2M
Royalty Pharma plc(RPRX)Pablo Legorreta2025$0.9M

Note: All compensation values shown are grant-date fair value as reported in proxy statements. Direct comparisons should account for differences in company size, industry, and compensation structure.

Want to know when these numbers change?

We’ll email you when these companies file a new proxy — so you can see how CEO pay, equity awards, and ratios shift before the next headline.